The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations.

Neuro-oncology advances(2020)

引用 10|浏览25
暂无评分
摘要
This study highlights the importance of ligand-mediated Wnt/β-catenin signaling as well as its drugable potency in -mutant meningioma.
更多
查看译文
关键词
FOXM1,ICG-001,Merlin protein,NF2-mutant meningioma,β-catenin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要